By Professor Glenda Halliday

Journal articles

Dzamko N; Chua G; Ranola M; Rowe DB, 2013, 'Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients', Journal of Parkinson S Disease, 3, pp. 145 - 152, http://dx.doi.org/10.3233/JPD-130174

Dzamko N; Halliday GM, 2013, 'Unlocking the secrets of LRRK2 function with selective kinase inhibitors', Future Neurology, 8, pp. 347 - 357, http://dx.doi.org/10.2217/fnl.13.9

Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DMA; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E, 2013, 'A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies', JAMA Neurology, 70, pp. 727 - 735, http://dx.doi.org/10.1001/jamaneurol.2013.1925

Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT, 2013, 'Disease duration and the integrity of the nigrostriatal system in Parkinson's disease', Brain, 136, pp. 2419 - 2431, http://dx.doi.org/10.1093/brain/awt192

Halliday GM, 2013, 'Motor deficits associated with changes in β-amyloid in Parkinson's disease', Journal of Neurology Neurosurgery and Psychiatry, 84, pp. 475 - 476, http://dx.doi.org/10.1136/jnnp-2012-304177

Ravenscroft TA; Baker MC; Rutherford NJ; Neumann M; Mackenzie IR; Josephs KA; Boeve BF; Petersen R; Halliday GM; Kril J; van Swieten JC; Seeley WW; Dickson DW; Rademakers R, 2013, 'Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS', Neurobiology of Aging, 34, pp. 2235 - 2235.e13, http://dx.doi.org/10.1016/j.neurobiolaging.2013.04.004

Tan RH; Pok K; Wong S; Brooks D; Halliday GM; Kril JJ, 2013, 'The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease', Acta neuropathologica communications, 1, pp. 30, http://dx.doi.org/10.1186/2051-5960-1-30

Kim WS; Hsiao JT; Bhatia S; Glaros E; Don AS; Tsuruoka S; Shannon Weickert CS; Halliday GM, 2013, 'ABCA8 stimulates sphingomyelin production in oligodendrocytes', Biochemical Journal, 452, pp. 401 - 410, http://dx.doi.org/10.1042/BJ20121764

Abbott SK; Jenner AM; Mitchell T; Brown S; Halliday GM; Garner B, 2013, 'An Improved High-Throughput lipid extraction method for the analysis of human brain lipids', Lipids, 48, pp. 307 - 318, http://dx.doi.org/10.1007/s11745-013-3760-z

Kragh CL; Fillon G; Gysbers A; Hansen HD; Neumann M; Richter-Landsberg C; Haass C; Zalc B; Lubetzki C; Gai WP; Halliday GM; Kahle PJ; Jensen PH, 2013, 'FAS-Dependent Cell Death in á-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy', PLoS ONE, 8, pp. Article numbere 55243, http://dx.doi.org/10.1371/journal.pone.0055243

Dobson-Stone C; Luty A; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field C; Panegyres P; Hecker J; Solski JA; Blair I; Fullerton JM; Halliday GM; Schofield PR; Kwok J; Schofield P, 2013, 'Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: Genetic, clinical and neuropathological analysis', ACTA Neuropathologica, 125, pp. 523 - 533, http://dx.doi.org/10.1007/s00401-013-1078-9

Davies KM; Hare DJ; Cottam V; Chen N; Hilgers L; Halliday GM; Mercer JFB; Double KL, 2013, 'Localization of copper and copper transporters in the human brain', Metallomics, 5, pp. 43 - 51, http://dx.doi.org/10.1039/c2mt20151h

Guerreiro PS; Huang Y; Gysbers A; Cheng D; Gai WP; Outeiro TF; Halliday GM, 2013, 'LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models', Journal of Molecular Medicine - Jmm, 91, pp. 513 - 522, http://dx.doi.org/10.1007/s00109-012-0984-y

Tan RH; Wong S; Hodges JR; Halliday GM; Hornberger M, 2013, 'Retrosplenial Cortex (BA 29) Volumes in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease', Dementia and Geriatric Cognitive Disorders, 35, pp. 177 - 182, http://dx.doi.org/10.1159/000346392

Reyes S; Fu Y; Double KL; Cottam V; Thomp LH; Kirik D; Paxinos G; Watson C; Cooper HM; Halliday GM, 2013, 'Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease', Neurobiology of Aging, 34, pp. 873 - 886, http://dx.doi.org/10.1016/j.neurobiolaging.2012.07.019

Thanos SM; Halliday GM; Damian DL, 2012, 'Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans', BRITISH JOURNAL OF DERMATOLOGY, 167, pp. 631 - 636, http://dx.doi.org/10.1111/j.1365-2133.2012.11109.x

Huang Y; Chegini F; Chua G; Murphy K; Gai W; Halliday GM, 2012, 'Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation', Translational Neurodegeneration, 1, http://dx.doi.org/10.1186/2047-9158-1-2

Fu Y; Yuan Y; Halliday GM; Rusznak Z; Watson C; Paxinos G, 2012, 'A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse', Brain Structure and Function, 217, pp. 591 - 612, http://dx.doi.org/10.1007/s00429-011-0349-2

Wong J; Higgins M; Halliday GM; Garner B, 2012, 'Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease', Neuroscience, 210, pp. 363 - 374, http://dx.doi.org/10.1016/j.neuroscience.2012.02.037

Lewis SJG; Shine JM; Duffy S; Halliday GM; Naismith SL, 2012, 'Anterior cingulate integrity: Executive and neuropsychiatric features in Parkinson's disease', Movement Disorders, 27, pp. 1262 - 1267, http://dx.doi.org/10.1002/mds.25104

Huang Y; Halliday GM, 2012, 'Aspects of innate immunity and Parkinson's disease', Frontiers in Pharmacology, 3, pp. Art. No. 33, http://dx.doi.org/10.3389/fphar.2012.00033

Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok J, 2012, 'C9ORF72 repeat expansion in clinical and neuropathological frontotemporal dementia cohorts', Neurology, 79, pp. 995 - 1001

Kim WS; Halliday , 2012, 'Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression', Journal of Parkinson's Disease, 2, pp. 41 - 46, http://dx.doi.org/10.3233/JPD-2012-11059

Sarchio SNE; Kok L-F; O'Sullivan C; Halliday GM; Byrne SN, 2012, 'Dermal mast cells affect the development of sunlight-induced skin tumours', EXPERIMENTAL DERMATOLOGY, 21, pp. 241 - 248, http://dx.doi.org/10.1111/j.1600-0625.2012.01438.x

Halliday GM; Mccann H; Shepherd CE, 2012, 'Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?', Expert Review of Neurotherapeutics, 12, pp. 673 - 686, http://dx.doi.org/10.1586/ern.12.47

Reyes S; Fu Y; Double KL; Thompson L; Kirik D; Paxinos G; Halliday GM, 2012, 'GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area', Journal of Comparative Neurology, 520, pp. 2591 - 2607, http://dx.doi.org/10.1002/cne.23051

Hornberger M; Wong S; Tan R; Irish M; Piguet O; Kril J; Hodges JR; Halliday GM, 2012, 'In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease', Brain, 135, pp. 3015 - 3025, http://dx.doi.org/10.1093/brain/aws239

Shine JM; Halliday GM; Carlos M; Lewis SJG; Naismith S, 2012, 'Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm', Movement Disorders, 27, pp. 500 - 505, http://dx.doi.org/10.1002/mds.24900

Sharpe LJ; Wong J; Garner B; Halliday GM; Brown AJ, 2012, 'Is seladin-1 really a selective Alzheimer's disease indicator?', Journal of Alzheimer's Disease, 30, pp. 35 - 39, http://dx.doi.org/10.3233/JAD-2012-111955

Elliott DA; Kim WS; Gorissen SV; Halliday GM; Kwok J, 2012, 'Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease', Movement Disorders, 27, pp. 1004 - 1011, http://dx.doi.org/10.1002/mds.25005

Halliday GM; Bigio EH; Cairns NJ; Neumann M; Mackenzie IRA; Mann DM, 2012, 'Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects', ACTA Neuropathologica, 124, pp. 373 - 382, http://dx.doi.org/10.1007/s00401-012-1030-4

Valenzuela MJ; Matthews F; Brayne C; Ince P; Halliday GM; Kril J; Dalton M; Richardson K; Forster G; Sachdev PS, 2012, 'Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia', Biological Psychiatry, 71, pp. 783 - 791, http://dx.doi.org/10.1016/j.biopsych.2011.07.036

Wong J; Garner B; Halliday G; Kwok J, 2012, 'P4‐372: Evidence of altered TrkB pre‐mRNA splicing in Alzheimer's disease', Alzheimer's & Dementia, 8, http://dx.doi.org/10.1016/j.jalz.2013.08.153

Kavanagh T; Mills JD; Kim WS; Halliday GM; Janitz M, 2012, 'Pathway analysis of the human brain transcriptome in disease', Journal of Molecular Neuroscience, Published online, http://dx.doi.org/10.1007/s12031-012-9940-0

Stevens CH; Rowe DB; Morel-Kopp MC; Orr CF; Russell T; Ranola M; Ward CM; Halliday GM, 2012, 'Reduced T helper and B lymphocytes in Parkinson's disease', Journal of Neuroimmunology, 252, pp. 95 - 99, http://dx.doi.org/10.1016/j.jneuroim.2012.07.015

Lim YA; Giese M; Shepherd CE; Halliday GM; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Gotz J, 2012, 'Role of hippocalcin in mediating Abeta toxicity', Biochimica et Biophysica ACTA - Molecular Basis of Disease, 1822, pp. 1247 - 1257, http://dx.doi.org/10.1016/j.bbadis.2012.04.007

Schwartz RS; Halliday GM; Cordato DJ; Kril JJ, 2012, 'Small-vessel disease in patients with Parkinson's disease: A clinicopathological study', Movement Disorders, 27, pp. 1506 - 1512, http://dx.doi.org/10.1002/mds.25112

Wong JCY; Garner B; Halliday GM; Kwok JBJ, 2012, 'Srp20 regulates TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer's disease', Journal of Neurochemistry, 123, pp. 159 - 171, http://dx.doi.org/10.1111/j.1471-4159.2012.07873.x

Schofield E; Hodges JR; Bak T; Xuereb JH; Halliday GM, 2012, 'The relationship between clinical and pathological variables in Richardson's syndrome', Journal of Neurology, 259, pp. 482 - 490, http://dx.doi.org/10.1007/s00415-011-6205-8

Farrell AW; Halliday GM; Lyons JG, 2011, 'Chromatin structure following UV-induced DNA damage-repair or death?', International Journal of Molecular Sciences, 12, pp. 8063 - 8085, http://dx.doi.org/10.3390/ijms12118063

Bock VL; Lyons JG; Huang XXJ; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM, 2011, 'BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours', British Journal of Dermatology, 164, pp. 1221 - 1227, http://dx.doi.org/10.1111/j.1365-2133.2011.10267.x

Damian DL; Matthews YJ; Phan TA; Halliday GM, 2011, 'An action spectrum for ultraviolet radiation-induced immunosuppression in humans', British Journal of Dermatology, 164, pp. 657 - 659, http://dx.doi.org/10.1111/j.1365-2133.2010.10161.x

Zhou J; Broe M; Huang Y; Anderson JA; Gai WP; Milward EA; Porritt MJ; Howells DW; Hughes AJ; Wang X; Halliday GM, 2011, 'Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease', ACTA Neuropathologica, 121, pp. 695 - 704, http://dx.doi.org/10.1007/s00401-011-0815-1

Sachdev PS; Lee T; Lammel A; Crawford J; Trollor JN; Wright MJ; Brodaty H; Ames D; Martin NG, 2011, 'Cognitive functioning in older twins: The Older Australian Twins Study', Australasian Journal on Ageing, 30, pp. 17 - 23, http://dx.doi.org/10.1111/j.1741-6612.2011.00534.x

Chen-Plotkin A; Martinez-Lage M; Sleiman PMA; Hu W; Greene R; Wood EF; Bing S; Grossman M; Schellenberg GD; Hatanpaa K; Weiner M; White III CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach T; Graff-radford N; Dickson D; Rademakers R; Boeve B; Pickering-Brown SM; Snowden J; Van Swieten JC; Heutink P; Seelaar H; Murrell J; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio EH; Llado A; Miller B; Alzualde A; Moreno FS; Rohrer JD; Mackenzie IRA; Feldman H; Hamilton RL; Cruts M; Engelborghs ; De Deyn PP; Van Broeckhoven C; Bird T; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van deerlin VM, 2011, 'Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration', Archives of Neurology, 68, pp. 488 - 497

Halliday GM; Stevens C, 2011, 'Glia: Initiators and progressors of pathology in Parkinson's disease', Movement Disorders, 26, pp. 6 - 17, http://dx.doi.org/10.1002/23455

Huang Y; Rowe DB; Halliday , 2011, 'Interaction between a-synuclein and tau genotypes and the progression of Parkinson's disease', Journal of Parkinson's Disease, 1, pp. 271 - 276, http://dx.doi.org/10.3233/JPD-2011-11027

Masters CL; Kril J; Halliday GM; Pamphlett R; Collins S; Hill AF; McLean CA, 2011, 'Overview and recent advances in neuropathology. Part 2: Neurodegeneration', Pathology, 43, pp. 93 - 102, http://dx.doi.org/10.1097/PAT.0b013e3283426eee

Dobson‐Stone C; Luty A; Hallupp M; Coupland K; Brooks W; Panegyres P; Piguet O; Broe GA; Sobow T; Zekanowski C; Halliday G; Schofield P; Kwok J, 2011, 'P1‐285: Sigma non‐opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.566

Kwok J; Luty A; Dobson‐Stone C; Loy C; Brooks W; Karlström H; Halliday G; Schofield P, 2011, 'P1‐287: Positional cloning identifies SIGMAR1 gene as a causative locus for FTLD‐MND in a large Australian pedigree', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.568

Back to profile page